Cystic Fibrosis Trial, Recruiting NCT07071324 Sponsor: Johns Hopkins University Condition: Cystic Fibrosis
Back to Cystic Fibrosis

Cystic Fibrosis Trial, Recruiting

NCT07071324
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have an official diagnosis of Cystic Fibrosis (CF) recorded in your medical records
  • You have scored higher than 4 on a fatigue measurement scale called the Fatigue Severity Scale (confirm with trial site)
  • You have access to a smartphone, tablet, or computer with an internet connection
  • You are able to understand, read, and speak English
  • You receive your CF care at one of the CF centers taking part in this study

Who may not be able to join:

  • You have had a lung infection flare-up (pulmonary exacerbation) within 14 days before or after signing up for the trial, which may include being treated with oral antibiotics, IV antibiotics, or a hospital stay
  • You are currently pregnant or have given birth within the last 6 months
  • Your doctor has advised against light physical activity for any reason, such as lung, heart, or joint/muscle concerns
  • You previously took part in a study called the CFWP Feasibility Study
  • You are currently enrolled in another clinical trial that involves a treatment or intervention
  • You are not available to attend coaching sessions within the timeframe set by the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kristin Riekert, PhD, Johns Hopkins University

Phone: 4105507755

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 February 2026
Est. completion
30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Intervention Adherence as assessed by the number of CFWP participants; Participant Retention as assessed by the number of participants completing the week 15 assessment survey; Fitness Tracker Data Quality as assessed by the number of participants who have valid activity and sleep data.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov